Riskpilot← Back to searchSign inGet full accessNovius Holding AB
ABActiveOrg 5568756794Vaxmoravägen 25 BMedical specialists activities · NACE 8622Est. 20110 employees
Revenue 2024
SEK 0
EBITDA margin
—
-12% vs 2023
Equity ratio
13.6%
Financial strength
Net profit 2024
SEK 1,5M
-57% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -441K | -12% |
| Net profit | SEK 1,5M | -57% |
| Total assets | SEK 23,5M | +17% |
| Equity | SEK 3,2M | -16% |
| Employees | 0 | — |
Legal name
Novius Holding AB
Org number
5568756794
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 december 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall äga och förvalta aktier och värdepapper, dock utan att tillståndsplikt föreligger, bedriva specialistläkarverksamhet inom öppenvård, ej på sjukhus, samt idka därmed förenlig verksamhet.
Address
Vaxmoravägen 25 B
Email
christos.lenis@novius.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −591 | −2 929 | −406 | −393 | −441 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −591 | −2 929 | −406 | −393 | −441 |
| Net financials | 21 | 4 452 | 1 162 | 288 | 13 |
| Profit before tax | 3 131 | 6 823 | 6 460 | 4 373 | 1 973 |
| Tax | −749 | −1 091 | −1 093 | −945 | −502 |
| Net profit | 2 382 | 5 732 | 5 367 | 3 428 | 1 471 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 17 246 | 19 907 | 21 238 | 20 185 | 23 527 |
| Equity | 2 501 | 5 833 | 7 200 | 3 827 | 3 198 |
| Long-term debt | 3 038 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 483 | 1 490 | 1 614 | 4 551 | 8 132 |
| Total debt | 6 521 | 1 490 | 1 614 | 4 551 | 8 132 |
EBITDA margin
-44100000.0%
This company
15.8%
Market median
-279114024% vs market
20202024
Equity ratio
13.6%
This company
38.2%
Market median
-64% vs market
20202024
Return on equity
46.0%
This company
18.4%
Market median
+150% vs market
20202024
Net profit margin
147100000.0%
This company
8.1%
Market median
+1816049283% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
6.36×
This company
0.62×
Market median
-926% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CJ Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Novius Holding AB (this company)
Novius Kirurgi AktiebolagBoard members of Novius Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Jacob Mattias Biderholt | Chief Auditor | 0 companies |
| Konstantinos Lenis | Board of Directors | 0 companies |
| Christos Lenis | Deputy Board Member | 0 companies |